{"id":{"repo_id":"cornell","oai_identifier":"oai:ecommons.cornell.edu:1813/36082"},"canonical_url":"https://search.ndltd.org/etd/cornell/oai:ecommons.cornell.edu:1813/36082","repository":{"repo_id":"cornell","name":"Cornell University","base_url":"https://ecommons.cornell.edu/server/oai/request"},"display":{"title":"Bmac And Prp Enhance Migration Of Endogenous Mscs","abstract":"Bone marrow derived mesenchymal stem cells (MSCs) demonstrate promise for musculoskeletal regenerative medicine. An alternate approach to the direct delivery of stem cells is to exploit the concept of in situ tissue engineering. Biologics such as bone marrow aspirate concentrate and platelet rich plasma (PRP) enhance recovery from musculoskeletal injuries. These biologics contain growth factors which could act as chemoattractants for stem cells. In this project, we observed the migratory capacity of stem cells in response to biologics using of a microfluidics device. The purpose of this study was to identify the optimal biologic for recruitment of stem cells. Our hypothesis was that PRP would result in the greatest migration of MSC's because of the milieu and concentration of growth factors contained in PRP. We found that all biologics tested resulted in an increase in migration of stem cells compared to the control. This demonstrates that biologics can be used as chemotactic agents to recruit MSCs to a site of injury. This information will reduce the need and therefore the risks and costs associated with direct stem cell delivery.","abstract_html":"Bone marrow derived mesenchymal stem cells (MSCs) demonstrate promise for musculoskeletal regenerative medicine. An alternate approach to the direct delivery of stem cells is to exploit the concept of in situ tissue engineering. Biologics such as bone marrow aspirate concentrate and platelet rich plasma (PRP) enhance recovery from musculoskeletal injuries. These biologics contain growth factors which could act as chemoattractants for stem cells. In this project, we observed the migratory capacity of stem cells in response to biologics using of a microfluidics device. The purpose of this study was to identify the optimal biologic for recruitment of stem cells. Our hypothesis was that PRP would result in the greatest migration of MSC&#x27;s because of the milieu and concentration of growth factors contained in PRP. We found that all biologics tested resulted in an increase in migration of stem cells compared to the control. This demonstrates that biologics can be used as chemotactic agents to recruit MSCs to a site of injury. This information will reduce the need and therefore the risks and costs associated with direct stem cell delivery.","abstract_has_math":false,"creators":["Holmes, Hannah"],"institution":"Cornell University","degree_name":"M.S., Veterinary Medicine","degree_level":"Master of Science","degree_discipline":"Veterinary Medicine","degree_department":null,"school":null,"contributors":[],"advisors":[],"committee_chairs":["Fortier, Lisa Ann"],"committee_members":["Lin, David M.","Gilbert, Robert Owen"],"year":2014,"date_issued":"2014-01-27","date_published":"2014-01-27","updated_at":"2026-11-19T03:17:47Z","subjects":["mesenchymal stem cells","bone marrow aspirate concentrate","platelet rich plasma"],"languages":["en_US"],"rights":[],"rights_urls":[],"identifier_entries":[{"key":"dc:identifier.bibid","label":"Dc Identifier Bibid","values":["8442255"],"render_values":[{"text":"8442255","href":null,"code":true}]}],"person_identifier_entries":[]},"links":{"outbound_url":"https://hdl.handle.net/1813/36082","outbound_label":"Handle","outbound_source":"dc:identifier.uri","record_url":"https://hdl.handle.net/1813/36082","record_label":"Repository record","record_kind":"handle","record_source":"dc:identifier.uri","download_url":null,"download_label":null,"download_source":null,"access_status":null,"embargo_until":null,"access_note":null},"source_record":{"url":"https://ecommons.cornell.edu/server/oai/request?verb=GetRecord&metadataPrefix=dim&identifier=oai%3Aecommons.cornell.edu%3A1813%2F36082","prefix":"dim"},"metadata_groups":[{"id":"people","label":"People","entries":[{"key":"dc:contributor.chair","label":"Chair","values":["Fortier, Lisa Ann"]},{"key":"dc:contributor.committeemember","label":"Committee Member","values":["Lin, David M.","Gilbert, Robert Owen"]},{"key":"dc:creator","label":"Author","values":["Holmes, Hannah"]}]},{"id":"academic_context","label":"Academic Context","entries":[{"key":"dc:date.accessioned","label":"Dc Date Accessioned","values":["2014-02-25T18:40:18Z"]},{"key":"dc:date.available","label":"Dc Date Available","values":["2019-01-28T07:02:02Z"]},{"key":"dc:date.issued","label":"Date","values":["2014-01-27"]},{"key":"dc:type","label":"Dc Type","values":["dissertation or thesis"]},{"key":"thesis:degree_discipline","label":"Discipline","values":["Veterinary Medicine"]},{"key":"thesis:degree_level","label":"Degree Level","values":["Master of Science"]},{"key":"thesis:degree_name","label":"Degree Name","values":["M.S., Veterinary Medicine"]},{"key":"thesis:institution_name","label":"Thesis Institution Name","values":["Cornell University"]}]},{"id":"subjects_keywords","label":"Subjects and Keywords","entries":[{"key":"dc:subject","label":"Dc Subject","values":["mesenchymal stem cells","bone marrow aspirate concentrate","platelet rich plasma"]}]},{"id":"language_rights","label":"Language and Rights","entries":[{"key":"dc:language.iso","label":"Language (ISO)","values":["en_US"]}]},{"id":"identifiers","label":"Identifiers","entries":[{"key":"dc:identifier.bibid","label":"Dc Identifier Bibid","values":["8442255"]},{"key":"dc:identifier.uri","label":"Identifier URI","values":["https://hdl.handle.net/1813/36082"]}]},{"id":"additional","label":"Additional Metadata","entries":[{"key":"cerif:openaire","label":"Cerif Openaire","values":["<Publication xmlns=\"https://www.openaire.eu/cerif-profile/1.1/\" id=\"bd4d0b1d-e7ad-486c-8739-e11f608b0bda\"> <Type xmlns=\"https://www.openaire.eu/cerif-profile/vocab/COAR_Publication_Types\">http://purl.org/coar/resource_type/c_1843</Type> <Language>en_US</Language> <Title>Bmac And Prp Enhance Migration Of Endogenous Mscs</Title> <PublishedIn> <Publication> </Publication> </PublishedIn> <PublicationDate>2014-01-27</PublicationDate> <Authors> <Author> <DisplayName>Holmes, Hannah</DisplayName> <Affiliation> <OrgUnit> </OrgUnit> </Affiliation> </Author> </Authors> <Editors> </Editors> <Publishers> <Publisher> <OrgUnit /> </Publisher> </Publishers> <Keyword>mesenchymal stem cells</Keyword> <Keyword>bone marrow aspirate concentrate</Keyword> <Keyword>platelet rich plasma</Keyword> <Abstract>Bone marrow derived mesenchymal stem cells (MSCs) demonstrate promise for musculoskeletal regenerative medicine. An alternate approach to the direct delivery of stem cells is to exploit the concept of in situ tissue engineering. Biologics such as bone marrow aspirate concentrate and platelet rich plasma (PRP) enhance recovery from musculoskeletal injuries. These biologics contain growth factors which could act as chemoattractants for stem cells. In this project, we observed the migratory capacity of stem cells in response to biologics using of a microfluidics device. The purpose of this study was to identify the optimal biologic for recruitment of stem cells. Our hypothesis was that PRP would result in the greatest migration of MSC's because of the milieu and concentration of growth factors contained in PRP. We found that all biologics tested resulted in an increase in migration of stem cells compared to the control. This demonstrates that biologics can be used as chemotactic agents to recruit MSCs to a site of injury. This information will reduce the need and therefore the risks and costs associated with direct stem cell delivery.</Abstract> <Access xmlns=\"http://purl.org/coar/access_right\" > </Access> </Publication>"]},{"key":"cris:virtual.author","label":"Cris Virtual Author","values":["Holmes, Hannah"]},{"key":"cris:virtualsource.collection","label":"Cris Virtualsource Collection","values":["5893a6ea-7af3-41d7-abc6-04bcd26ab5df"]},{"key":"dc:description.abstract","label":"Abstract","values":["Bone marrow derived mesenchymal stem cells (MSCs) demonstrate promise for musculoskeletal regenerative medicine. An alternate approach to the direct delivery of stem cells is to exploit the concept of in situ tissue engineering. Biologics such as bone marrow aspirate concentrate and platelet rich plasma (PRP) enhance recovery from musculoskeletal injuries. These biologics contain growth factors which could act as chemoattractants for stem cells. In this project, we observed the migratory capacity of stem cells in response to biologics using of a microfluidics device. The purpose of this study was to identify the optimal biologic for recruitment of stem cells. Our hypothesis was that PRP would result in the greatest migration of MSC's because of the milieu and concentration of growth factors contained in PRP. We found that all biologics tested resulted in an increase in migration of stem cells compared to the control. This demonstrates that biologics can be used as chemotactic agents to recruit MSCs to a site of injury. This information will reduce the need and therefore the risks and costs associated with direct stem cell delivery."]},{"key":"dc:description.collection","label":"Dc Description Collection","values":["Cornell Theses and Dissertations"]},{"key":"dc:format.mimetype","label":"Dc Format Mimetype","values":["application/pdf"]},{"key":"dc:title","label":"Title","values":["Bmac And Prp Enhance Migration Of Endogenous Mscs"]},{"key":"dspace:entity.type","label":"Dspace Entity Type","values":["Publication"]},{"key":"others:access_status","label":"Others Access Status","values":["open.access"]}]}],"canonical_facts":{"cerif:openaire":["<Publication xmlns=\"https://www.openaire.eu/cerif-profile/1.1/\" id=\"bd4d0b1d-e7ad-486c-8739-e11f608b0bda\"> <Type xmlns=\"https://www.openaire.eu/cerif-profile/vocab/COAR_Publication_Types\">http://purl.org/coar/resource_type/c_1843</Type> <Language>en_US</Language> <Title>Bmac And Prp Enhance Migration Of Endogenous Mscs</Title> <PublishedIn> <Publication> </Publication> </PublishedIn> <PublicationDate>2014-01-27</PublicationDate> <Authors> <Author> <DisplayName>Holmes, Hannah</DisplayName> <Affiliation> <OrgUnit> </OrgUnit> </Affiliation> </Author> </Authors> <Editors> </Editors> <Publishers> <Publisher> <OrgUnit /> </Publisher> </Publishers> <Keyword>mesenchymal stem cells</Keyword> <Keyword>bone marrow aspirate concentrate</Keyword> <Keyword>platelet rich plasma</Keyword> <Abstract>Bone marrow derived mesenchymal stem cells (MSCs) demonstrate promise for musculoskeletal regenerative medicine. An alternate approach to the direct delivery of stem cells is to exploit the concept of in situ tissue engineering. Biologics such as bone marrow aspirate concentrate and platelet rich plasma (PRP) enhance recovery from musculoskeletal injuries. These biologics contain growth factors which could act as chemoattractants for stem cells. In this project, we observed the migratory capacity of stem cells in response to biologics using of a microfluidics device. The purpose of this study was to identify the optimal biologic for recruitment of stem cells. Our hypothesis was that PRP would result in the greatest migration of MSC's because of the milieu and concentration of growth factors contained in PRP. We found that all biologics tested resulted in an increase in migration of stem cells compared to the control. This demonstrates that biologics can be used as chemotactic agents to recruit MSCs to a site of injury. This information will reduce the need and therefore the risks and costs associated with direct stem cell delivery.</Abstract> <Access xmlns=\"http://purl.org/coar/access_right\" > </Access> </Publication>"],"cris:virtual.author":["Holmes, Hannah"],"cris:virtualsource.collection":["5893a6ea-7af3-41d7-abc6-04bcd26ab5df"],"dc:contributor.chair":["Fortier, Lisa Ann"],"dc:contributor.committeemember":["Lin, David M.","Gilbert, Robert Owen"],"dc:creator":["Holmes, Hannah"],"dc:date.accessioned":["2014-02-25T18:40:18Z"],"dc:date.available":["2019-01-28T07:02:02Z"],"dc:date.issued":["2014-01-27"],"dc:description.abstract":["Bone marrow derived mesenchymal stem cells (MSCs) demonstrate promise for musculoskeletal regenerative medicine. An alternate approach to the direct delivery of stem cells is to exploit the concept of in situ tissue engineering. Biologics such as bone marrow aspirate concentrate and platelet rich plasma (PRP) enhance recovery from musculoskeletal injuries. These biologics contain growth factors which could act as chemoattractants for stem cells. In this project, we observed the migratory capacity of stem cells in response to biologics using of a microfluidics device. The purpose of this study was to identify the optimal biologic for recruitment of stem cells. Our hypothesis was that PRP would result in the greatest migration of MSC's because of the milieu and concentration of growth factors contained in PRP. We found that all biologics tested resulted in an increase in migration of stem cells compared to the control. This demonstrates that biologics can be used as chemotactic agents to recruit MSCs to a site of injury. This information will reduce the need and therefore the risks and costs associated with direct stem cell delivery."],"dc:description.collection":["Cornell Theses and Dissertations"],"dc:format.mimetype":["application/pdf"],"dc:identifier.bibid":["8442255"],"dc:identifier.uri":["https://hdl.handle.net/1813/36082"],"dc:language.iso":["en_US"],"dc:subject":["mesenchymal stem cells","bone marrow aspirate concentrate","platelet rich plasma"],"dc:title":["Bmac And Prp Enhance Migration Of Endogenous Mscs"],"dc:type":["dissertation or thesis"],"dspace:entity.type":["Publication"],"others:access_status":["open.access"],"thesis:degree_discipline":["Veterinary Medicine"],"thesis:degree_level":["Master of Science"],"thesis:degree_name":["M.S., Veterinary Medicine"],"thesis:institution_name":["Cornell University"]},"updated_at":"2026-11-19T03:17:47Z"}